Novo Nordisk's Bloomington facility received an OAI label from the FDA due to compliance issues, including contamination by extrinsic particles. Scholar Rock's drug application was rejected due to ...
The Food and Drug Administration recalled nearly 85 million units through the first half of the year and managing this ...
The FDA has approved an updated indication for upadacitinib (Rinvoq; AbbVie) in inflammatory bowel disease (IBD), allowing its use in adults with moderately to severely active ulcerative colitis or ...
By creating a new, simple nutrition label that goes on the front-of-package (FOP), the FDA believes they can make nutrition ...
The US Food and Drug Administration (FDA) has approved AbbVie’s supplemental new drug application, updating the indication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback